CTIS.eu › Cities › Belgium › Leuven
Leuven
Belgium
1,135 total trials
478 recruiting
Filter these 1,135 trials by phase, condition, sponsor and more.
Open in Search →
2023-508015-23-00
5
2025-04-11
Ovarian cancer recurrent
2024-512659-19-00
10
2025-03-31
Advanced Melanoma
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
2024-515506-11-00
4
2025-03-24
Urothelial Carcinoma
2024-512536-29-00
4
2025-02-28
Amyotrophic Lateral Sclerosis (ALS)
2024-512126-29-00
5
2025-02-25
Generalized Myasthenia Gravis
2023-505252-21-00
4
2025-02-14
Hyperkalemia
2023-504655-27-00
5
2024-12-23
Primary Indeterminate Lesions or Small Choroidal Melanoma
2024-514135-17-00
5
2024-11-28
Immunoglobulin A Nephropathy
2023-507746-83-00
5
2024-11-27
Generalized Myasthenia Gravis
2023-503630-44-00
10
2024-11-20
Treatment of moderate-to-severe Atopic dermatitis
2022-503112-17-00
5
2024-10-16
Limb-girdle muscular dystrophy, type 2E/R4 (LGMD2E/R4) or β-sarcoglyca
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
2023-509618-12-00
5
2024-09-11
Crohn's Disease (CD)
2024-512839-70-00
1
2024-08-27
Advanced and/or Metastatic Solid Tumors
2023-505678-14-00
4
2024-08-19
Ulcerative Colitis
2023-509566-38-00
9
2024-08-05
gastroesophageal junction adenocarcinoma
2023-504773-20-00
5
2024-08-01
Active Chronic Pouchitis
2023-507539-40-00
4
2024-07-19
Myasthenia Gravis
2023-503699-25-00
5
2024-07-15
Progressive Pulmonary Fibrosis
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
2023-503697-21-01
5
2024-06-24
Idiopathic pulmonary fibrosis
2023-503904-10-00
5
2024-06-07
Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
2023-504308-27-00
5
2024-06-06
non-squamous non-small cell lung cancer
Showing 145–168 of 1,135 trials